Turing Biosystems

Turing Biosystems is at the forefront of biotechnology research, dedicated to revolutionizing drug development and personalized medicine. Harnessing the power of computation, Turing Biosystems strives to deliver the right drugs, for the right people, at the right time, significantly improving patient outcomes. The company's innovative approach addresses the high failure rates and adverse immune responses associated with immunotherapy and cell & gene therapy.

Turing Biosystems' software platform, built on a new kind of interpretable AI that works through automated reasoning, integrates all modes of clinical and biological data. Powered by specialized chips, this platform analyzes patient responses to therapies and designs better healthcare interventions. Turing Biosystems is committed to supporting both clinicians and biopharmaceutical companies in delivering the most effective treatments to patients.

Based in London, with a primary address at London, EC2A 2BB, GB, and also operating from Lyon, FR, Turing Biosystems is poised to transform the healthcare landscape. The company's commitment to innovation and precision medicine positions it as a key player in the biotechnology sector. We invite the manager of Turing Biosystems to create a customized and exclusive company showcase and product listing on our platform.